<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01129830</url>
  </required_header>
  <id_info>
    <org_study_id>VCRM 3</org_study_id>
    <nct_id>NCT01129830</nct_id>
  </id_info>
  <brief_title>The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve</brief_title>
  <official_title>The Effect of DHEA on Markers of Ovarian Reserve in Women With Diminished Ovarian Reserve</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Virginia Center for Reproductive Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Virginia Center for Reproductive Medicine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective study evaluates the effect of DHEA supplementation on markers of ovarian
      reserve in women with diminished ovarian reserve.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Ovarian reserve markers, such as FSH, estradiol, AMH, ovarian volume and antral follicle
      counts will be monitored on DHEA supplementation in a prospective fashion.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Suboptimal recruitment
  </why_stopped>
  <start_date>January 2010</start_date>
  <completion_date type="Actual">September 2014</completion_date>
  <primary_completion_date type="Actual">September 2014</primary_completion_date>
  <phase>Early Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth rate</measure>
    <time_frame>3 years</time_frame>
    <description>Live birth rate will be monitored for women who took DHEA supplementation</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>number of oocytes</measure>
    <time_frame>3 years</time_frame>
    <description>Number of retrieved oocytes for patients undergoing IVF will be monitored along with ovarian response</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">200</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>Dehydroepiandrosterone</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>infertile women with low anti mullerian hormone levels</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>dehydroepiandrosterone</intervention_name>
    <description>DHEA supplementation 25 mg tid for 3 months</description>
    <arm_group_label>Dehydroepiandrosterone</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  infertile women with diminished ovarian reserve

        Exclusion Criteria:

          -  women &gt; 45
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>44 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Fady I Sharara, M.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>Virginia Center for Reproductive Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Virginia Center for Reproductive Medicine</name>
      <address>
        <city>Reston</city>
        <state>Virginia</state>
        <zip>20190</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Barad D, Brill H, Gleicher N. Update on the use of dehydroepiandrosterone supplementation among women with diminished ovarian function. J Assist Reprod Genet. 2007 Dec;24(12):629-34. Epub 2007 Dec 11.</citation>
    <PMID>18071895</PMID>
  </reference>
  <verification_date>September 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2010</study_first_submitted>
  <study_first_submitted_qc>May 24, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 25, 2010</study_first_posted>
  <last_update_submitted>September 18, 2014</last_update_submitted>
  <last_update_submitted_qc>September 18, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 22, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Virginia Center for Reproductive Medicine</investigator_affiliation>
    <investigator_full_name>Fady I. Sharara, M.D</investigator_full_name>
    <investigator_title>Medical Director</investigator_title>
  </responsible_party>
  <keyword>ovarian reserve</keyword>
  <keyword>FSH</keyword>
  <keyword>anti-mullerian hormone</keyword>
  <keyword>estradiol</keyword>
  <keyword>oocyte</keyword>
  <keyword>IVF</keyword>
  <keyword>embryo transfer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dehydroepiandrosterone</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

